Before Market Opens

Juniper Hotels Ltd, affiliated with the global Hyatt brand, has announced its Initial Public Offering (IPO) scheduled for February 21-23, 2024, aiming to raise ₹1,800 crore. The offering is purely a fresh issue of shares, priced between ₹342 to ₹360 each, with the listing planned on both BSE and NSE. The proceeds are intended for debt repayment and general corporate purposes. With a significant stake in India’s luxury hotel segment, the company reported a substantial increase in revenue for the fiscal year 2023, showcasing strong financial performance and recovery. This IPO presents an investment opportunity in a leading entity within India’s thriving hospitality industry​

Juniper Hotels Ltd Set to Launch ₹1,800 Crore IPO Under Hyatt Brand

Before Market Opens

The initial public offering (IPO) of Vibhor Steel Tubes Ltd, held from February 13 to February 15, 2024, witnessed an extraordinary investor response, with the subscription reaching 27.63 times according to BSE data. Retail and non-institutional investors led the demand, with their portions subscribed 32.51 and 48.33 times respectively. The grey market premium (GMP) stood at ₹132, suggesting a high level of investor confidence and a potential listing price significantly above the IPO price band of ₹141-₹151 per share. The company aims to raise ₹72.17 crore for funding working capital requirements and for general corporate purposes. With manufacturing facilities in Maharashtra and Telangana, Vibhor Steel Tubes specializes in producing steel pipes and tubes for various engineering industries, demonstrating notable financial growth in recent years

Vibhor Steel Tubes IPO Sees Overwhelming Subscription, GMP Indicates Strong Investor Confidence

Before Market Opens

Medi Assist, a prominent third-party administrator in India’s insurance sector, is preparing for its IPO. The company boasts a dominant market share, serving a significant portion of general insurance companies in India, and has shown strong financial growth over recent years. Key strengths include a stable and trustworthy management team, advanced technology infrastructure, and significant partnerships with government healthcare programs. However, investors should be cautious about the high valuation, as indicated by a high price-to-earnings ratio, and the nature of the IPO, which is entirely an Offer For Sale by existing shareholders, meaning no new capital will be raised for the company. Additionally, the company’s reliance on insurance companies for outsourcing and increasing working capital requirements present potential risks. As with any investment, thorough personal research and consideration of individual financial objectives and risk tolerance are crucial before participating in the IPO

Medi Assist’s IPO: Strong Market Position and Financial Performance, but High Valuation and Offer for Sale Structure Pose Considerations